| BSE Code | Company | Start Date | Purpose |
|---|---|---|---|
| 541929 | Synergy Green Synergy Green Industries Ltd | 19-May-2026 | Synergy Green Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2026 inter alia to consider and approve Intimation of Board meeting which will be held on 19.05.2026 to approve Audited Financial Results for FY 2025-26 and declaration of dividend. |
| 541556 | Rites Rites Ltd | 19-May-2026 | RITES Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2026 ,inter alia, to consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the Quarter and Financial Year ended on March 31, 2026 and to consider recommendation of final dividend, if any on equity shares of the Company, for the Financial Year 2025-26. |
| 541557 | Fine Organic Fine Organic Industries Ltd | 19-May-2026 | Fine Organic Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2026 ,inter alia, to consider and approve As enclosed |
| 541400 | Zim Laboratories Zim Laboratories Ltd | 19-May-2026 | Audited Results |
| 541445 | Waa Solar Waa Solar Ltd | 19-May-2026 | Waa Solar Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2026 ,inter alia, to consider and approve the Standalone and Consolidated Audited Financial Results for the Half year and Year ended on March 31, 2026. |
| 542057 | BCPL Railway BCPL Railway Infrastructure Ltd | 19-May-2026 | Final Dividend & Audited Results BCPL Railway Infrastructure Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2026 ,inter alia, to consider and approve 1. Audited Financial Statements standalone and consolidated for the quarter and financial year ended March 31, 2026. 2. Recommending Final Dividend, if any. 3. Recommending reappointment of Mr Ranajit Mondal (DIN: 06430495) with effect from 14.08.2026 to function as Independent Directors for a term of 5 years. 4. Recommending reappointment of M/s L B Jha & Co. as the Statutory Auditors of the Company for a period of 5 years subject to approval of the shareholders. 5. Considering issues pertaining to the Annual General Meeting. 6. General business discussions. |
| 543904 | Mankind Pharma Mankind Pharma Ltd | 19-May-2026 | Mankind Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2026 inter alia to consider and approve standalone and consolidated audited financial results of the Company for the quarter and financial year ended on March 31 2026 and realignment of security cover provided in respect of existing Non-Convertible Debentures. |
| 543283 | United Foodbrands United Foodbrands Ltd | 19-May-2026 | Quarterly Results & Audited Results United Foodbrands Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2026 ,inter alia, to consider and approve the audited standalone and consolidated financial results of the Company for the quarter and financial year ended March 31, 2026. (As Per BSE Announcement Dated On : 12.05.2026) |
| 543482 | Eureka Forbes Eureka Forbes Ltd | 19-May-2026 | Eureka Forbes Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2026 ,inter alia, to consider and approve Audited Standalone and Consolidated Financial Statements and Results of the Company for the Quarter and Financial Year ended March 31, 2026. |
| 543427 | Medplus Health Medplus Health Services Ltd | 20-May-2026 | Medplus Health Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider and approve the audited Standalone and Consolidated Financial Results of the Company for the Quarter and Financial year ended March 31 2026. The Board Meeting to be held on 29/05/2026 has been revised to 20/05/2026 The Board Meeting to be held on 29/05/2026 has been revised to 20/05/2026 to consider and approve the audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ended March 31, 2026. (As Per BSE Announcement Dated on 03.05.2026) |
Old Backoffice
Data available till FY 2024-25 (Historical)
New Backoffice
Data From FY 2025-26 onwards (Latest)
